
07 Dec 2023
Oxford BioMedica# (OXB LN, 475p, Buy) (Downgrade) - Model overhaul: clear new guidance and decisive action taken
This content is only available within our institutional offering.

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Oxford BioMedica# (OXB LN, 475p, Buy) (Downgrade) - Model overhaul: clear new guidance and decisive action taken
Oxford BioMedica plc (OXB:LON) | 590 -171 (-4.7%) | Mkt Cap: 708.6m
- Published:
07 Dec 2023 -
Author:
Miles Dixon -
Pages:
25 -